Cabaletta Bio (CABA) Insider Trading & Ownership $2.44 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.43 -0.01 (-0.37%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cabaletta Bio (NASDAQ:CABA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.25%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$210.74KNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$1.50M Get CABA Insider Trade Alerts Want to know when executives and insiders are buying or selling Cabaletta Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CABA Insider Buying and Selling by Quarter Cabaletta Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/19/2024Gwendolyn BinderInsiderSell11,000$19.59$215,490.00 12/19/2023Gwendolyn BinderInsiderSell11,000$21.89$240,790.00 10/19/2023Gwendolyn BinderInsiderSell11,000$13.36$146,960.00 9/19/2023Gwendolyn BinderInsiderSell11,000$17.57$193,270.00 8/21/2023Gwendolyn BinderInsiderSell11,000$13.42$147,620.00 7/19/2023Gwendolyn BinderInsiderSell11,000$13.82$152,020.00 6/20/2023Gwendolyn BinderInsiderSell11,000$12.99$142,890.00 5/19/2023Gwendolyn BinderInsiderSell22,000$11.81$259,820.00 10/18/2022Anup MardaCFOBuy50,000$0.99$49,500.00 10/18/2022Catherine BollardDirectorBuy1,000$0.99$990.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/18/2022Gwendolyn BinderInsiderBuy20,000$0.99$19,800.00 10/18/2022Steven NichtbergerCEOBuy141,873$0.99$140,454.27 (Data available from 1/1/2013 forward) CABA Insider Trading Activity - Frequently Asked Questions Who is on Cabaletta Bio's Insider Roster? The list of insiders at Cabaletta Bio includes Anup Marda, Catherine Bollard, Gwendolyn Binder, and Steven Nichtberger. Learn more on insiders at CABA. What percentage of Cabaletta Bio stock is owned by insiders? 11.25% of Cabaletta Bio stock is owned by insiders. Learn more on CABA's insider holdings. Which Cabaletta Bio insiders have been selling company stock? The following insider sold CABA shares in the last 24 months: Gwendolyn Binder ($603,240.00). How much insider selling is happening at Cabaletta Bio? Insiders have sold a total of 33,000 Cabaletta Bio shares in the last 24 months for a total of $603,240.00 sold. Cabaletta Bio Key ExecutivesDr. Steven A. Nichtberger M.D. (Age 63)Co-Founder, Chairman, CEO & President Compensation: $1.02MDr. Gwendolyn K. Binder Ph.D. (Age 49)President of Science & Technology Compensation: $722.62kDr. David J. Chang FACR (Age 61)M.D., M.P.H., Chief Medical Officer Compensation: $721.85kDr. Michael C. Milone M.D.Ph.D., Co-Founder & Co-Chair of Scientific Advisory BoardDr. Aimee Payne M.D.Ph.D., Co-Founder & Co-Chair of Scientific Advisory BoardMr. Anup Marda M.B.A. (Age 46)Chief Financial Officer Compensation: $548.2kDr. Samik Basu M.D.Chief Scientific OfficerMr. Michael Gerard J.D. (Age 44)General Counsel & Secretary Ms. Heather Harte-Hall M.Sc.Chief Compliance OfficerMs. Martha O'ConnorChief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies TSHA Insider Trading RZLT Insider Trading SANA Insider Trading KOD Insider Trading XNCR Insider Trading SEPN Insider Trading IOVA Insider Trading PHAT Insider Trading NAGE Insider Trading VIR Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold?NuScale, Rocket Lab Face Heavy Insider Selling After Surges This page (NASDAQ:CABA) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cabaletta Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
